mp.weixin.qq.com·· 3 hours agoPickScore91
Precision Care for HER2-Altered Advanced NSCLC Continues to Advance
In brief
Precision treatment of advanced NSCLC with HER2 mutations or overexpression is moving from later-line ADC therapy toward first-line regimens and combination treatment, and HER2 TKIs are adding to the treatment options.
Why it matters
The article places ADC, TKI and combination therapy data for HER2-mutant and overexpressed NSCLC in one framework, aiding comparison across lines and biomarkers.
Source: mp.weixin.qq.com · mp.weixin.qq.com